Pure Global

Development and Adaptation of I-STRONG for SCD - Trial NCT06110754

Access comprehensive clinical trial information for NCT06110754 through Pure Global AI's free database. This phase not specified trial is sponsored by Emory University and is currently Recruiting. The study focuses on Sickle Cell Disease. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06110754
Recruiting
behavioral
Trial Details
ClinicalTrials.gov • NCT06110754
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Development and Adaptation of I-STRONG for SCD
Integrative Training Program for Pediatric Sickle Cell Pain: Development and Adaptation of I-STRONG for SCD

Study Focus

Sickle Cell Disease

I-STRONG for SCD

Interventional

behavioral

Sponsor & Location

Emory University

Atlanta,Cincinnati, United States of America

Timeline & Enrollment

N/A

Oct 24, 2023

Sep 30, 2024

12 participants

Primary Outcome

Change in Brief Pain Inventory (BPI) Pain Severity Score

Summary

This study develops and tests the feasibility and acceptability of an adapted intervention,
 Integrative Strong Body and Mind Training (I-STRONG), in adolescents with pain from sickle
 cell disease.

ICD-10 Classifications

Sickle-cell disorders
Other sickle-cell disorders
Sickle-cell trait
Sickle-cell anaemia with crisis
Sickle-cell anaemia without crisis

Data Source

ClinicalTrials.gov

NCT06110754

Non-Device Trial